TrialEuropean journal of clinical investigation2026

Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients.

Marta Toledano-Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.